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ABSTRACT
Short read massive parallel sequencing has emerged
as a standard diagnostic tool in the medical set-
ting. However, short read technologies have inher-
ent limitations such as GC bias, difficulties mapping
to repetitive elements, trouble discriminating paral-
ogous sequences, and difficulties in phasing alle-
les. Long read single molecule sequencers resolve
these obstacles. Moreover, they offer higher con-
sensus accuracies and can detect epigenetic mod-
ifications from native DNA. The first commercially
available long read single molecule platform was the
RS system based on PacBio’s single molecule real-
time (SMRT) sequencing technology, which has since
evolved into their RSII and Sequel systems. Here we
capsulize how SMRT sequencing is revolutionizing
constitutional, reproductive, cancer, microbial and
viral genetic testing.
INTRODUCTION
Modern medical genomics research and diagnostics relies
heavily on DNA sequencing. Sequencing technologies are
used in a wide range of applications during the entire hu-
man lifespan, from prenatal diagnostics, to newborn screen-
ing, to diagnosing rare diseases, hereditary forms of can-
cer, pharmacogenetics testing and predisposition testing
for a plethora of diseases. It can even include testing for
future generations in terms of carrier screening and pre-
implantation genetic diagnoses (1,2).
The history of sequencing technologies can be broken
up into three phases: first-, second- and third-generation
sequencing (3). Though earlier first-generation technolo-
gies provided ground breaking discoveries, the big revolu-
tion in sequencing began with the invention of the ‘chain-
termination’ or dideoxy technique, or what is today called
Sanger sequencing (3,4). Improvements in chemistry and
switching from gels to capillary based electrophoresis led to
the current Sanger machines that provide low-throughput,
high quality reads of up to ∼1 kb. Sanger sequencing is still
often referred to as the gold standard and is commonly used
for diagnosingMendelian disorders (5) and targeted valida-
tion of higher-throughput sequencing results.
The first decade of the 21st century brought forth the
development of multiple new methods of DNA sequenc-
ing (6). As opposed to first-generation platforms, these new
second-generation technologies have considerably shorter
reads (up to a few hundred bps), but at massively higher
throughput (up to billions of reads per run). Common
short-read platforms based on fluorescence include Illu-
mina’s bridge amplification and sequencing by synthesis
technologies (e.g. HiSeq and MiSeq), Roche 454 pyrose-
quencers, and Applied Biosystem’s sequencing by oligonu-
cleotide ligation and detection (SOLiD) platforms. Ad-
ditional short-read platforms include the Ion Torrent se-
quencers that detect nucleotides by the difference in pH as
a result of hydrogen ions emitted during polymerisation, as
opposed to light signals. Though these short-read platforms
have permitted scientists to quickly hunt for causative mu-
tations in a panel of disease genes, the exome, or even the en-
tire human genome in both research and clinical settings (7),
they all share common pitfalls and drawbacks. The short
read lengths hinder assigning reads to complex parts of the
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Figure 1. Overview of SMRT Sequencing Technology. Sequencing starts
with preparing a library from double stranded DNA (A) to which hairpin
genome (8), phasing of variants (9), resolving repeat regions
(10) and introduce gaps and ambiguous regions in de novo
assemblies (11,12). The amplification steps during library
preparation and/or the actual sequencing reaction also in-
troduce chimeric reads (13), variation in repeat size, and
an underrepresentation of GC-rich/poor regions. Taken to-
gether, these drawbacks hinder the utility of diagnostic vari-
ant detection.
Third-generation is in general characterized as single
molecule sequencing and is fundamentally different from
clonal based second generation sequencing methods. He-
licos provided the first commercial application of single
molecule sequencing based on fluorescence detection and
sequencing by synthesis. Though lacking amplification bi-
ases, such as underrepresentation of GC-rich/poor re-
gions, this early single molecule sequencing still produced
short (often 35 bp) read lengths (14). Two newer tech-
nologies, single molecule real-time (SMRT) sequencing by
Pacific Biosciences (PacBio) (15) and nanopore sequenc-
ing by Oxford Nanopore Technologies (16), offer the ad-
vantages of single molecule sequencing, including excep-
tionally long read lengths (>20 kb). These platforms per-
mit sequencing/assembly through repetitive elements, di-
rect variant phasing, and even direct detection of epige-
netic modifications (17,18). Sequencing also only lasts sev-
eral hours, which is very appealing in a diagnostic setting.
Though simple and low-cost nanopore based technologies
(reviewed in (18–20)) are catching on and likely represent
future platforms, SMRT sequencing is currently more ma-
tured and therefore diagnostically applicable at this time.
Here we review how SMRT sequencing is being imple-
mented in human genetic diagnostics.
SMRT SEQUENCING TECHNOLOGY AND TERMI-
NOLOGY
Before SMRT sequencing, a library needs to be prepared
from double stranded DNA input material (Figure 1A).
Typically this often requires five or more micrograms of
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
adapters are ligated (B). This library is thereafter loaded onto a SMRT
Cell made up of nanoscale observation chambers (ZeroModeWaveguides
(ZMWs)). The DNA molecules in the library will be pulled to the bottom
of the ZMW where the polymerase will incorporate fluorescently labelled
nucleotides (C). Note that not all ZMWs will contain a DNAmolecule be-
cause the library is loaded by diffusion. The fluorescence emitted by the nu-
cleotides is recorded by a camera in real-time. Hence, not only the fluores-
cence color can be registered, but also the time between nucleotide incorpo-
ration which is called the interpulse duration (IPD) (D, right panel). When
a sequencing polymerase encounters nucleotides on the DNA strand con-
taining an (epigenetic) modification, like for example a 6-methyl adenosine
modification (E, left panel), then the IPD will be delayed (E, right panel)
compared to non-methylated DNA (D, right panel). Due to the circular
structure of the library, a short insert will be covered multiple times by the
continuous long read (CLR). Each pass of the original DNA molecule is
termed a subread, which can be combined into one highly accurate con-
sensus sequence termed a circular consensus sequence (CCS) or reads-of-
insert (ROI) (F–H, left panel). Though SMRT sequencing always uses a
circular template, long insert libraries typically only have a single pass and
hence generate a linear sequence with single pass error rates (black nu-
cleotides) (FG, right panel). Afterwards, overlapping single passes can be
combined into one consensus sequence of high quality (H, right panel).
Overall, CCS reads have the advantage of being very accurate while single
passes stand out for their long read lengths (>20 kb).
Downloaded from https://academic.oup.com/nar/advance-article-abstract/doi/10.1093/nar/gky066/4833218
by guest
on 08 February 2018
Nucleic Acids Research, 2018 3
DNAwhich can limit some applications. The library prepa-
ration consists of simply ligating hairpin adapters onto
DNA molecules, thereby circularizing them into a con-
struct termed a SMRTbell (Figure 1B) (21). Next, a primer
and a polymerase are annealed to the adapter whereupon
the library is loaded on a SMRT Cell containing 150 000
nanoscale observation chambers (Zero Mode Waveguides
(ZMWs)) for the RSII system and up to a million on the
newer Sequel platform. The polymerase bound SMRTbells
are then loaded into the ZMWs (Figure 1C). Ideally as
many ZMWs should be loaded with exactly one SMRT-
bell as possible to maximise throughput and read lengths.
For a good run, this is around one third to one half of
the ZMWs per SMRT cell. Hence a SMRT cell typically
produces ∼55 000 reads for the RSII system and 365 000
reads for the Sequel system (Table 1). The actual sequencing
reaction occurs within each ZMW, whose small diameter
only permits the smallest available volume for light detec-
tion (22). The polymerase within each ZMW incorporates
fluorescently labeled nucleotides, emitting a fluorescent sig-
nal that is recorded by a camera in real-time (Figure 1C).
These signals are converted to long sequences termed con-
tinuous long reads (CLR) (22), linear reads, or polymerase
reads. For a short insert library, the circular structure of the
molecule results in the insert sequence being covered mul-
tiple times by the CLR. Each pass of an original strand is
termed a subread. In addition, all subreads from the same
molecule can be combined into one highly accurate consen-
sus sequence termed a circular consensus sequence (CCS)
or reads-of-insert (ROI) (Figure 1F–H, left panel). These
two terms are often used interchangeably, but by definition
the difference is CCS requires two full sequencing passes of
the insert whereas ROI can be defined starting from even a
partial pass.
Due to the real-time detection of the nucleotide incorpo-
ration rate, the pace of the polymerase progressing through
the DNA strand is registered during sequencing (23). The
time between nucleotide incorporations is termed the in-
terpulse duration (IPD) and varies with epigenetic changes
on the DNA (Figure 1D and E). Since a polymerase is not
holding a single nucleotide during sequencing, but approx-
imately twelve nucleotides, an epigenetic change on one nu-
cleotide can actually affect the incorporation rate of sur-
rounding nucleotides. This results in a ‘fingerprint,’ (24)
some of which have been characterized, such as for 6-mA,
4-mC and (Tet-converted) 5-mC.
In addition to fewer but longer reads (Table 1), PacBio
data differs from short read sequencing technologies in sev-
eral aspects. Reads are not a set read length, but a distribu-
tion of read lengths depending on how long each individual
polymerase is active. Since there is no need for amplifica-
tion during the library preparation, nor during the sequenc-
ing process, biases such as GC-skewing are near absent. In
contrary to second-generation platforms, raw PacBio reads
also differ in error types (more indels than mismatches) and
have a much higher abundance (∼13–15%, Table 1), though
they are spread randomly across the reads (25,26). This
randomness enables highly accurate consensuses (>99%)
to be build up rapidly by sequencing multiple times the
same molecule (CCS reads) (15) or by combining differ-
ent CLRs derived from the same locus (Figure 1G and H).
Also, diffusion loading creates a preference towards shorter
molecules which might negatively impact sequencing runs.
This loading bias can be mitigated by using magbead load-
ing which keeps molecules <1 kb from binding to the bot-
tom of ZMWs, size selection to remove short molecules,
and/or by adding polyethylene glycol during loading to en-
hance packing of large DNAmolecules. It is possible that a
complete length independent loading can be achieved in the
(near) future by applying an electrical field to force charged
molecules into ZMW’s (27).
To address these inherently different reads, bioinformatic
analyses require adapting current tools and/or developing
new methods, such as for alignment (26,28–32) and as-
sembly (33–39). Many PacBio specific tools and pipelines
(including those for demultiplexing, creating CCS reads,
long amplicon analyses, de novo assemblies (34) and epi-
genetic analyses) are available in PacBio’s SMRT analysis
suite (openly available, www.pacb.com/support/software-
downloads/) via the command line or their SMRT Portal
and SMRT Link graphical user interfaces.
CONSTITUTIONAL
Tandem repeat disorders
Tandem repeats cause more than 40 neurological, neurode-
generative or neuromuscular diseases when mutated (40).
Unfortunately, sequencing those DNA elements is difficult
with short-read platforms because the reads are too short
to span most tandem repeats. The first tandem repeat stud-
ied by SMRT sequencing was the FMR1 CGG repeat (41).
Healthy individuals carry around 30 CGG units which is
mostly interrupted by one or two AGG units. An expansion
of the repeat to more than 200 units causes the Fragile X
Syndrome (FXS), which is one of the most frequent causes
of inherited intellectual disability and autism. Loomis et al.
(41) showed they could sequence through a long full mu-
tation allele of 750 units which equals 2 kb of 100% GC
and repetitive content. Interestingly, expansions to full mu-
tations only occur upon maternal transmission whereby the
risk directly correlates with increasing repeat size and fewer
AGG interruptions (42). SMRT sequencing can be used to
determine the repeat size and the detection of the number
of interrupting AGG units (43). A main advantage of this
approach is the unambiguous separation of the two CGG
repeats on the different X chromosomes of females thereby
outperforming all other (PCR) approaches. Afterward, the
information generated by SMRT sequencing is used clini-
cally for improved genetic counselling of woman weighing
the risk of having a child with FXS (43–45). Another ex-
ample of tackling a tandem repeat by SMRT sequencing is
the ATTCT repeat embedded in intron 9 of the Spinocere-
bellar ataxia type 10 gene (SCA10) (10). For the first time
the full length of an expanded ATTCT repeat was com-
pletely sequenced using SMRT technology. The repeat was
reconstructed by assembly and both known and novel in-
terruptions were detected (10). The presence of those inter-
ruptions influence the phenotype of SCA10 patients and
hence knowing the exact repeat structure allows for bet-
ter genotype-phenotype correlations. It will be interesting
to use SMRT sequencing in the near future for other tan-
dem repeats with interruptions like Myotonic Dystrophy
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Table 1. Comparison of PacBio sequencing platforms to two current industry standards
Platform Read length Number reads Error rate Run rime
PacBio RSII (per SMRT cell) Average 10–16 kb ∼55 000 13–15% 0.5–6 hours
PacBio Sequel (per SMRT cell) Average 10–14 kb ∼365 000 13–15% 0.5–10 hours
Illumina HiSeq 4000 2 × 150 bp 5 billion ∼0.1% <1–3.5 days
Illumina MiSeq 2 × 300 bp 25 million ∼0.1% 4–55 hours
Numbers from personal experience and company website (www.pacb.com and www.illumina.com) queries on 14 November 2017.
(46) and Friedreich’s Ataxia (47) to increase our knowledge
on tandem repeat configuration, its influence on stability of
the repeat, and phenotype of an individual.
Where all of the above applications use PCR, novel am-
plification free enrichment methods are currently being de-
veloped. Methods using amplification are very error-prone,
especially when amplifying (tandem) repeats (41), and re-
move all epigenetic marks (48). Thus using amplification
impedes a complete genetic and epigenetic characterization
of tandem repeats. Currently two methods are under devel-
opment. The first method presented by Pham et al. (48) is
based on type IIS restriction enzyme digestions, customized
hairpin adapters especially designed to anneal at the tar-
geted digest overhangs, and a ‘capture-hook’ method. A
second andmore recentmethod (bioRxiv https://doi.org/10.
1101/203919) is based on restriction enzyme digestion fol-
lowed by cleavage of SMRT bells containing the target of
interest using the CRISPR/Cas9 system. By ligating a spe-
cific capture adapter at the CRISPR/Cas9 DNA cleavage
sites, the SMRT bell molecules of interest can then be se-
lectively pulled down by magnetic beads targeting the cap-
ture adapter. The high throughput of SMRT sequencing en-
ables different targets (e.g. FMR1 CGG repeat, C9ORF72
GGGGCC repeat, HTT CAG repeat, Sca10 ATTCT re-
peat, etc.) from one DNA sample to be simultaneously en-
riched and sequenced in a single run (bioRxiv https://doi.
org/10.1101/203919).
Both methods have been used to target the FMR1 CGG
repeat and showed for the first time the true biological CGG
repeat variation in human cell lines (48) (bioRxiv https://doi.
org/10.1101/203919). Besides avoiding amplification biases,
these methods permit native DNA capture and hence direct
detection of epigenetics. In the future, this technique can
possibly be used diagnostically to screen for full mutations
and assess themethylation status of the FMR1CGG repeat,
both of which influence the phenotype of FXS (49–51).
Traditionally this would be determined by Southern blots,
a labour intensive and inaccurate method. Thus replacing
Southern Blots with faster and more direct SMRT sequenc-
ing will greatly enhance FMR1 and additional repeat dis-
order diagnostics (49–52). PacBio’s enrichment technique
has also been used to study patients with expanded Sca10
ATTCT repeats (53). Here, SMRT sequencing revealed a
complete absence of interruptions which could be linked to
the parkinsonism phenotype of the patient.
Polymorphic regions
Genotyping the human leukocyte antigen (HLA) region,
or the human major histocompatibility complex (MHC),
is crucial for diagnosing autoimmune disorders and selec-
tion of donors in organ and stem cell transplantation.Genes
in the region can be highly polymorphic, HLA-B being
the most variable with >2000 alleles already annotated in
2012 (54). The high variability in sequence make this re-
gion exceptionally difficult to map with short reads (54).
HLA can be divided into three molecule classes and re-
gions, termed class I, II and III, though the first two are
primarily studied. Amplicons of ∼400–900 bp have been
used with 454 sequencing to target specific exons of class I
genes (55,56). However, considering these genes are ∼3kb
in length, entire alleles, as opposed to exons, can be se-
quenced in a single PacBio read. Class II genes can exceed
10kb making them more difficult, but still possible. Full
length class I HLA alleles have been targeted in humans
with hybrid PacBio-Illumina approaches (57) and PacBio
only approaches (58,59). Many large HLA typing labs, such
as the Anthony Nolan Research Institute (58,59), are utiliz-
ing or developing SMRT sequencing pipelines of their own
or using commercial kits, such as those offered by GenDx
(Utrecht, The Netherlands), to now target class I, as wells
asmany class II genes. This is rapidly expanding the number
of knownHLA alleles (57) and is becoming a gold standard
for organ transplant genotyping and blood stem cell trans-
plantation.
Similarly complex regions can also be analyzedwith these
approaches. The killer cell immunoglobulin-like receptor
(KIR) region, whose genes encode proteins with domains
that recognize HLA proteins, was recently analyzed with
SMRT sequencing and for the first timemultiple haplotypes
were phased without imputation (60).
Pseudogene discrimination
The high sequence similarity between pseudogenes and
their homologous functional genes makes distinguishing
variation between the two extremely difficult when using
short read technologies. In general, long reads spanning
the actual gene regions can be used to anchor to unique
regions and/or phase variants to discriminate between
the pseudogene and the actual gene. For diagnostics it
is common to target a specific locus or set of loci of
interest as a cost effective way to overcome the limited
throughput of current generation SMRT sequencing
platforms. The easiest option to enrich for specific loci is
amplifying the targets by doing a (multiplex) long-range
PCR (up to 10 kb). To differentiate samples, barcodes
can be added directly during PCR via primers (61,62),
by a nested PCR approach (57,61,63,64), or by ligating
hairpin adapters containing barcodes during library
preparation (Pacific Biosciences Product Note: www.pacb.
com/wp-content/uploads/2015/09/ProductNote-Barcoded-
Adapters-Barcoded-Universal-Primers.pdf). Therefore,
for multiplexed long-amplicon tests only a single library
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preparation is needed after pooling the barcoded ampli-
cons, as opposed to fragmentation and multiple barcoded
library preparations for short-read platforms. This there-
fore enables fast, cheap library preparations that can be
sequenced in just a few hours, permitting the next step in
complex gene loci diagnoses.
One application is using barcoded 6–8 kb amplicons, and
potential nested amplicons, to target the drug metabolism
gene CYP2D6 (61,63). This gene has homologous pseudo-
genes and copy number variants which impair reliable geno-
typing with short-read platforms (61,63). After SMRT se-
quencing, reads can then be aligned and variants called us-
ing alignment based or ‘Long Amplicon Analysis’ (LAA,
included in SMRT analysis) based pipelines. LAA is par-
ticularly powerful in that it enables reference free analyses
and phasing of the two alleles (61). The pipeline first demul-
tiplexes reads (if needed), then looks for overlap, performs
clustering (i.e. determines different amplicons), phases the
clustered reads (i.e. determines different alleles), and deter-
mines consensus sequences with Quiver (34). LAA may re-
quire optimization, such as the minimal number of reads
used for clustering. Too many can result in false alleles
and long run times, whereas too little may result in allelic
dropouts. Once assembled, alleles can be compared to each
other or to a reference genome for annotation. Overall,
SMRT sequencing permits expanding from targeting spe-
cific CYP2D6 variants/exons, to identification of phased
variants across the entire loci, including up/downstream
and all introns, that will enhance identification of metabo-
lizer phenotypes in tested individuals and enhance person-
alized medicine (61). Similar long-range PCR with PacBio
applications have been used to genotype and discriminate
other genes from pseudogenes (Table 2), including PKD1
for diagnosing autosomal-dominant polycystic kidney dis-
ease (64) and IKBKG for diagnosing primary immunode-
ficiency diseases in patients suffering from life-threatening
invasive pyogenic bacterial infections (65).
REPRODUCTIVE GENOMICS
Reproductive genomic medicine and associated counseling,
including pre-implantation genetic diagnosis (PGD), relies
heavily on the ability to haplotype or phase alleles in em-
bryos, patients, and parents. Long reads enable direct phas-
ing of amplicons from targeted loci which can be used to
determine parent-of-origin alleles in embryos or patients
(66,67). In a family having one child with Treacher Collins
syndrome, SMRT amplicons sequencing was used to con-
firm the paternal transmission of a TCOF1 variant that af-
fects splicing of the gene and potentially causes the disease
(67). For apparent de novo mutations that are a result of
germ line mosaicism, determining the frequency of dam-
aging alleles is informative in predicting recurrence in fu-
ture offspring. For a couple with multiple miscarriages and
suspected Noonan syndrome in the fetuses, SMRT ampli-
con sequencing identified a disease causing PTPN11 vari-
ant in 37% of the father’s sperm (67). Digital Droplet PCR
showed no signs of the variant in the father’s blood, but con-
firmed the 40% frequency in the fathers sperm (67). This
therefore enabled an estimate of recurrent risk for subse-
quent pregnancies. Whole-genome single-cell haplotyping
based on arrays is already being used in practice for em-
bryo selection before implantation, though phasing still re-
quires additional family members (68). We envision a pro-
found impact on future PGD applications by incorporating
long-read whole-genome sequencing for direct phasing to
eliminate the need for analyzing additional familymembers.
CANCER
During treatment of cancer patients, it is crucial to moni-
tor low frequency mutations that can lead to a proliferative
advantage of malignant cells. Chronic myeloid leukemia
(CML) is a blood cancer that is caused by a translocation
between chromosomes 9 and 22, giving rise to the BCR-
ABL1 fusion protein. CML patients are normally treated
with tyrosine kinase inhibitors (TKIs) to suppress BCR-
ABL1, but the therapy can induce point mutations lead-
ing to drug resistance. It is therefore important to screen
the BCR-ABL1 gene in CML patients responding poorly
to TKI treatment and study the mutational landscape. In
a study by Cavelier et al. (69), a ∼1.5 kb amplicon was
constructed fromBCR-ABL1 cDNA. SMRT sequencing al-
lowed for detection of TKI resistance mutations down to a
level of 1%, a significantly lower detection threshold as com-
pared to the 15–20% reached by Sanger sequencing. More-
over, it was possible to phase co-existing mutations thereby
giving new information about the clonal distribution of re-
sistance mutations in BCR-ABL1, and also to identify a
number of distinct splice isoforms. Apart from BCR-ABL1,
a number of other cancer genes are suitable targets for
clinical SMRT sequencing (Table 2). In a study of loss-of-
function mutations in the tumor suppressor TP53, SMRT
sequencing revealed that tumors from acute myeloblastic
leukemia (AML) and myelodysplatic syndrome (MDS) pa-
tients harbor multiple TP53mutations distributed in differ-
ent alleles (70). In the future, detailed information about the
subclonal heterogeneity of TP53 could be used to guide the
treatment of these patients. Minor variants can also be de-
tected in other types of somatic variation, unrelated to can-
cer. Gudmunsson et al. (71) used SMRT sequencing to ob-
tain phasing information of somatic mosaicism mutations
in GJB2 that led to the repair of skin lesions in a patient
with keratitis-ichthyosis-deafness syndrome.
Whole genome and transcriptome sequencing (addressed
in later sections) is at the moment only affordable for re-
search, but in the near future will become a diagnostic op-
tion. Already whole genome and transcriptome SMRT se-
quencing has been applied to breast cancer cell models iden-
tifying novel gene fusion events with the known oncogene
Her2 (Case Study: www.pacb.com/wp-content/uploads/
Case-Study-Scientists-deconstruct-cancer-complexity-
through-genome-and-transcriptome-analysis.pdf). Whole
transcriptome sequencing of prostate cell models has also
identified novel RLN1 and RLN2 gene fusions in prostate
cancer (72). Importantly, SMRT sequencing can give a
more precise view of the cancer gene structure, as was
demonstrated in a study by Kohli et al. where a cryptic
exon was detected in AR-V9 that was previously thought
to be present only in AR-V7 (73). AR-V7 has been studied
as a potential biomarker for drug resistance in prostate
cancer, based on knockdown experiments that have in fact
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Table 2. Applications of human SMRT sequencing and clinical utility
Target Disease Ref.
Tandem repeat sequencing
FMR1 Fragile X Syndrome (43)a
HTT Huntington’s Disease a
C9orf72 Amyotrophic Lateral Sclerosis (ALS) a
SCA10 Spinocerebellar ataxia type 10, Parkinson’s disease (10,53)a
Highly polymorphic regions
HLA Autoimmune disorders & transplantation (57–59)
KIR Autoimmune diseases & transplantation (60)
Pseudogene discrimination
CYP2D6 Drug metabolism (61,63)
PKD1 Autosomal-dominant polycystic kidney disease (64)
IKBKG Primary immunodeficiency diseases (65)
Cancer
BCR-ABL1 Chronic Myeloid Leukemia (CML) (69)
TP53 Myelodysplastic Syndromes (MDS) and Acute Myeloblastic Leukemia (AML) (70)
Reproductive genomics
TCOF1 Treacher Collins syndrome (67)
PTPN11 Noonan syndrome (67)
abioRxivhttps://doi.org/10.1101/203919.
targeted both isoforms. Thus, AR-V9 may actually be a
predictive biomarker for resistance.
Global changes in epigenetics is also a hallmark in can-
cer. Single molecule real-time bisulfite sequencing (SMRT-
BS) enables quantitative and highly multiplexed detection
of methylation in 1.5–2 kb amplicons (74,75). This is an
improvement of the previous technologies that could only
target typical bisulfite PCR sizes (∼300–500 bp) and poten-
tially enables ∼91% of CpG islands in the human genome
to be evaluated (75). To date this has been applied to multi-
ple cancer cell lines, including those from an acute myeloid
leukemia, chronic myeloid leukemia, anaplastic large cell
lymphoma, plasma cell leukemia, Burkitt lymphoma, B-
cell lymphoma and multiple myelomas (75). Expanding
to genome wide diagnostics, when whole genome SMRT
sequencing is performed on non-amplified material it is
theoretically possible to determine epigenetic status across
all nucleotides based on IPD ratios. Therefore, we envi-
sion in the near future cancer genomes, transcriptomes and
epigenomes will commonly be characterized at previously
unparalleled resolution.
VIRAL AND MICROBIAL MEDICAL SEQUENCING
In infectious disease, SMRT sequencing has been used to
analyse influenza viruses (76), hepatitis B viruses (HBV)
(77), hepatitis C viruses (HCV) (77,78) and human immun-
odeficiency viruses (HIV) (79,80) (Table 3). HCV and HIV
are RNAmolecules of a length of approximately 9 kb, while
HBV is a circular DNA virus of size 3 kb. These viruses
are suitable subjects for SMRT sequencing, since the en-
tire virus genome can easily be contained in a single read.
For example, Bull et al. (77) developed an assay where the
resulting reads covered nearly the entire sequence for all
six major HCV genotypes. In addition to determining the
genome sequence of the infecting viruses, it is also possible
to monitor mutations that are developing as a result of drug
treatment. For HCV, resistance associated variants (RAVs)
in the NS5A gene occurring at a frequency of <0.5% were
successfully identified in samples from patients undergo-
ing treatment by direct acting antiviral drugs (DAAs) (78).
By full-length sequencing of the HIV-1 provirus, a 9700 bp
molecule that encodes nine major proteins via alternative
splicing, Ocwieja et al. (80) detected at least 109 different
spliced RNAs, including two of which encode new proteins.
The fact that this relatively small study could generate a lot
of novel information about HIV-1, a molecule that has al-
ready been studied in great detail, demonstrates the advan-
tage of full-length RNA sequencing to study the distribu-
tion of splicing isoforms in specific genes. Results from these
types of experiments could possibly open up novel thera-
peutic opportunities in infectious disease.
For bacteria, a single SMRT Cell often provides enough
data to de novo assemble Escherichia coli size genomes into
single contigs. HGAP is the most widely used assembler
and works by taking a selection of longest reads and er-
ror correcting them with all reads, followed by Celera as-
sembly (81,82), and finalized by polishing with all reads
aligned to the final assembly (34). These long reads and
new algorithms enable PacBio assemblies to be more com-
plete and accurate compared to second-generation sequenc-
ing methods (83,84). Clinically relevant bacterial assem-
blies include a strain of the Tuberculosis bacteria My-
cobacterium tuberculosis (85), the E. coli strain that caused
a Hemolytic–Uremic Syndrome outbreak in Germany in
2011 (86), and strains of Salmonella enterica subsp. enter-
ica serovar that cause gastroenteritis in humans (87) (Ta-
ble 3). Pacbio sequencing and HGAP have also been used
to assemble pathogenic single-cell eukaryote genomes that
are more complex than a single chromosome, such as for a
new Leishmania reference genome (88), a protozoan para-
site that kills >30 000 people each year.
Though long reads permit superb microbial assemblies,
what truly differentiates SMRT sequencing from second-
generation machines is the ability to directly determine the
epigenetics of these organisms. DNA methylation is over-
all ubiquitous in bacterial genomes (89), which simplifies
SMRT analysis of epigenetic characteristics in these organ-
isms. Analyses can be performed using IPD ratios of cases
versus controls or vs an in silico control compared to known
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Table 3. Medically relevant microbial SMRT sequencing
Target/disease Ref.
Hepatitis B/C virus (77,78)
HIV (79,80)
Influenza viruses (76)
Tuberculosis bacteria (85)
E. coli / Hemolytic–Uremic Syndrome (86)
Salmonella enterica subsp. enterica
serovar/gastroenteritis
(87)
Leishmania (88)
Leptospira interrogans/leptospirosis (90)
Helicobacter pylori strains/gastrointestinal
diseases
(91)
epigenetics signatures for 6-mA, 4-mC and (Tet converted)
5-mC (available in SMRT analysis). This has been used
to discriminate virulent from avirulent Leptospira interro-
gans, a cause of leptospirosis in humans (90). The genome
sequences have no major differences between strains, but
higher levels of methylation are found in the avirulent strain
(90).Methylation analysis has also been used to identify vir-
ulence factor genotype-dependent motifs in eight different
H. pylori strains, a bacteria that can lead to gastrointestinal
diseases (91). The simplicity to sequence, assemble, and call
nucleotide, structural and epigenetic variation for a com-
plete genome from a single SMRT Cell makes SMRT se-
quencing a truly revolutionizing technology in microbiol-
ogy.
FUTURE: WHOLE TRANSCRIPTOME AND GENOME
SEQUENCING
Traditionally RNA is converted to cDNA and then
fragmented for short read sequencing (RNA-seq). As-
sembling the host of exons detected from RNA-seq into
individual transcripts is extremely difficult and error
prone. SMRT sequencing eliminates the need for frag-
mentation, instead sequencing cDNAs from the 5′ end
of transcripts to the poly-A tail, termed Iso-Seq. This
is an ideal method for complete cDNA sequencing (92).
Iso-Seq has been used to sequence full transcriptomes
from the blood of a normal Chinese adult male (93), a
pool of 20 RNAs from different normal human tissues and
organs (92), a trio of lymphoblastoid transcriptomes (94),
and analyse prostate and breast cancer cell models (73)
(Case Study: www.pacb.com/wp-content/uploads/Case-
Study-Scientists-deconstruct-cancer-complexity-through-
genome-and-transcriptome-analysis.pdf). As opposed to
complex short-read alignment and re-assemblies, these
papers demonstrate long-reads can easily detect splicing
isoforms in human genes. Besides detecting a vast number
of known isoforms, this method has also identified novel
splicing forms and genes that have not previously been
detected by short-read sequencing (93). Similar to genomic
variant phasing, for gene loci with transcribed single nu-
cleotide variants, these can be used to determine precisely
which allele isoforms are expressed from (94). Though Iso-
Seq is exceptional for transcript structure determination,
the lower throughput when compared to second-generation
platforms currently limits its usage for expression analysis.
However, as costs drop and throughput increases, unbiased
PacBio expression and isoform detection will become
routine in the near future.
Whole genome sequencing (WGS) has become a widely
used method to study variation in the human genome,
and several 100’s of thousands of human genomes have
been sequenced with short-reads during the last few years.
However, the nature of these reads permit only rela-
tively small assemblies and alignments provide only lim-
ited information on variation outside of SNPs and small
insertions/deletions. SMRT sequencing is greatly expand-
ing the utility of WGS, permitting a factor greater in as-
sembly completeness (93,95) (BioRxiv: https://doi.org/10.
1101/067447), even nearing reference genome contig sizes
and including diploid aware assemblies by applying algo-
rithms like FALCON-unzip (37). These PacBioWGS’s also
demonstrate a vast repertoire of variation missed by short
read WGSs. Low coverage (4–8×) sequencing recently was
used to characterize structural variation in chromothrypsis-
like chromosomes (96) and identify a pathogenic heterozy-
gous 2184 bp deletion in a patient who presented with Car-
ney complex that could not be identified by short-read se-
quencing (97). Higher coverage sequencing (∼60×) of two
haploid genomes has also been used to identify a vast ar-
ray of structural variations (461 553 from 2 bp to 28 kb in
length), including>89%beingmissed in the analysis of data
from the 1000 Genomes Project (98). From this study, Hud-
dleston et al. (98) estimate a 5× increase in discovering in-
dels>7 bp and additional SVs<1 kb which in total bps rep-
resents a majority of the difference between genomes. Addi-
tional remarkable findings from individual human de novo
assemblies is that there seems to exist several megabases of
novel sequence, i.e. sequences that are absent from the cur-
rent (GRCh38) version of the human reference. For exam-
ple, Shi et al. (93) reported 12.8 Mb of novel sequence in
their de novo assembled individual genome, which would
correspond to over 0.4% of the entire human genome of size
∼3 Gb. At this point, it is not known whether this novel
sequence is common between all human individuals (and
thereby missing fromGRCh38) or if it mainly represents se-
quence variation found only in some specific individuals or
population groups. Overall, theseWGS studies demonstrate
long-read sequencing can identify a substantial number of
variation missed by short read platforms, including those
relevant to clinical diagnoses.
CONCLUSIONS
The myth that SMRT sequencing is too error prone to be
diagnostically useful is being expunged and replaced by ev-
idence that it offers advantages over short-read sequencers.
SMRT sequencing is opening up new diagnostic avenues,
such as the ability to determine tandem repeat lengths, in-
terruptions, and even epigenetics in a single test at base pair
resolution. Long read sequencing is already considered the
gold standard for some applications, such as for HLA geno-
typing for tissue transplants. While large scale implementa-
tion appears to be hampered by the cost and community
expertise, this is likely to change rapidly. In addition to sys-
tematic price reductions and a growing customer base, new
single molecule technologies such as nanopore based sys-
tems are likely to propel the field. Just as second-generation
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platforms stepped beyond Sanger sequencing and enabled
a revolution in genomics medicine, third-generation single
molecule sequencing platformswill likely be the next genetic
diagnostic revolution.
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